Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of New Oral Anticoagulants vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation

NCT03702582 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03702582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03702582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of New Oral Anticoagulants vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation
Lead sponsor
Massachusetts General Hospital
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2019
Completion date
October 1, 2023
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, bleeding, stroke